Agilent Technologies, Inc. (NYSE:A – Get Free Report) has received a consensus recommendation of “Hold” from the fourteen ratings firms that are currently covering the stock, Ratings reports. One ...

real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance ...

This webinar presents an optimized assay workflow using the Agilent Seahorse XF Pro Analyzer to profile T cell energy metabolism, enhancing the design and manufacturing of CAR-T cell therapies.

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use ...

The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$ ...

The new benchtop encloser can be equipped with interchangeable onboard air filtration options to protect samples from ...

The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$ 6.33 Billion in ...